Special Issue "Interleukin in Cancer Pathogenesis and Treatment"
Deadline for manuscript submissions: closed (15 November 2020).
Interests: cancer immunology; immunotherapy; clinical trials
Special Issues, Collections and Topics in MDPI journals
It is necessary to highlight the involvement of interleukins in the development and treatment of cancer, especially after the spectacular advances in immunotherapy and new cell therapies. It is also important to delve into the mechanisms of action and improvement of these treatments and the possible relationship with the interleukin family.
Dr. Carlos Alfaro
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- tumor pathogenesis
- cancer treatment